Epstein–Barr virus and cancer
PJ Farrell - Annual Review of Pathology: Mechanisms of …, 2019 - annualreviews.org
Epstein–Barr virus (EBV) contributes to about 1.5% of all cases of human cancer worldwide,
and viral genes are expressed in the malignant cells. EBV also very efficiently causes the …
and viral genes are expressed in the malignant cells. EBV also very efficiently causes the …
Learning from the nexus of autoimmunity and cancer
D Mangani, D Yang, AC Anderson - Immunity, 2023 - cell.com
The immune system plays critical roles in both autoimmunity and cancer, diseases at
opposite ends of the immune spectrum. Autoimmunity arises from loss of T cell tolerance …
opposite ends of the immune spectrum. Autoimmunity arises from loss of T cell tolerance …
Complementary Alu sequences mediate enhancer–promoter selectivity
L Liang, C Cao, L Ji, Z Cai, D Wang, R Ye, J Chen… - Nature, 2023 - nature.com
Enhancers determine spatiotemporal gene expression programs by engaging with long-
range promoters,,–. However, it remains unknown how enhancers find their cognate …
range promoters,,–. However, it remains unknown how enhancers find their cognate …
The human immunopeptidome project: a roadmap to predict and treat immune diseases
JA Vizcaíno, P Kubiniok, KA Kovalchik, Q Ma… - Molecular & Cellular …, 2020 - ASBMB
The science that investigates the ensembles of all peptides associated to human leukocyte
antigen (HLA) molecules is termed" immunopeptidomics" and is typically driven by mass …
antigen (HLA) molecules is termed" immunopeptidomics" and is typically driven by mass …
GWAS in cancer: progress and challenges
B Liang, H Ding, L Huang, H Luo, X Zhu - Molecular Genetics and …, 2020 - Springer
The genome-wide association study (GWAS) is an effective method to detect single-
nucleotide polymorphisms (SNPs) of multiple individual genes based on linkage …
nucleotide polymorphisms (SNPs) of multiple individual genes based on linkage …
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk
Estimating familial cancer risks is clinically important in being able to discriminate between
individuals in the population at differing risk for malignancy. To gain insight into the familial …
individuals in the population at differing risk for malignancy. To gain insight into the familial …
Primary immunodeficiency and cancer predisposition revisited: embedding two closely related concepts into an integrative conceptual framework
OA Haas - Frontiers in immunology, 2019 - frontiersin.org
Common understanding suggests that the normal function of a “healthy” immune system
safe-guards and protects against the development of malignancies, whereas a genetically …
safe-guards and protects against the development of malignancies, whereas a genetically …
[HTML][HTML] Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
FC Hamdy, JL Donovan, JA Lane… - Health Technology …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Prostate cancer is the most common cancer among men in the UK. Prostate-
specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as …
specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as …
NFkB pathway and hodgkin lymphoma
F Jardin - Biomedicines, 2022 - mdpi.com
The tumor cells that drive classical Hodgkin lymphoma (cHL), namely, Hodgkin and Reed-
Sternberg (HRS) cells, display hallmark features that include their rareness in contrast with …
Sternberg (HRS) cells, display hallmark features that include their rareness in contrast with …
Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma
Familial aggregation of Hodgkin lymphoma (HL) has been demonstrated in large population
studies, pointing to genetic predisposition to this hematological malignancy. To understand …
studies, pointing to genetic predisposition to this hematological malignancy. To understand …